Business Context and Reporting Period
Company: Aveanna Healthcare Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 26, 2026
Event: The Company's wholly owned subsidiary, Aveanna Healthcare LLC, entered into the thirteenth amendment to its First Lien Credit Agreement. This amendment constitutes a repricing and refinancing of existing debt facilities.
Key Financial Metrics and Debt Structure
This filing focuses on debt restructuring rather than operational financial performance. Key debt metrics include:
- 2026 Term Loans: Refinanced outstanding senior secured term loans with a new aggregate principal amount of $1,318,375,000.
- 2026 Refinancing Revolving Credit Facility: Refinanced existing $250,000,000 facility with a new $250,000,000 facility.
- Interest Rate Margins:
- Term SOFR Margin: 3.25% per annum.
- Base Rate Margin: 2.25% per annum.
- Reduction: The amendment resulted in a 0.50% reduction to applicable interest rate margins compared to the prior agreement.
- Rating Incentive: Margins may be reduced by an additional 0.25% if the Borrower obtains a credit rating of at least B2 or B.
Note: The filing text does not provide values for revenue, profit, cash flow, operating margins, or current liquidity positions.
Material Changes Versus Prior Period
The primary material change is the refinancing of the Company's senior secured debt facilities. The amendment replaced the existing term loans and revolving credit facility with new instruments under the "2026 Facilities." The most significant financial impact is the immediate reduction of interest rate margins by 0.50%, which is expected to lower future interest expenses. Other terms and conditions of the credit agreement were not materially amended.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on May 28, 2026, announcing the amendment. The filing indicates the Company intends to attach the full text of the amendment as an exhibit to its Quarterly Report on Form 10-Q for the quarter ended June 27, 2026.
Risks and Contingencies:
- Covenant Compliance: Interest rate margins on the revolving facility are subject to adjustments based on the Consolidated First Lien Net Leverage Ratio.
- Rating Dependency: Further margin reductions are contingent upon achieving specific credit ratings (B2 or B).
Note: The filing does not contain specific forward-looking guidance on revenue or earnings, nor does it detail specific risk factors beyond the standard debt covenants.
Investor Verification Checklist
- Verify the exact interest savings realized from the 0.50% margin reduction in the upcoming quarterly earnings report.
- Review the full text of the thirteenth amendment (to be filed in the Q2 2026 10-Q) for any non-financial covenant changes.
- Monitor the Company's Consolidated First Lien Net Leverage Ratio to determine if the revolving credit facility margins will adjust.
- Check for any credit rating agency actions regarding the potential B2/B rating threshold for additional margin reductions.